Ryan Barbara's Form 4 filing
MiNK Therapeutics, Inc. (INKT) · filed Jun 5, 2026
- Accession no.
- 0001193125-26-260084
- Filed
- Jun 5, 2026
- Trade date
- Jun 4, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $19.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ryan BarbaraCIK 0001827169 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | SSaleDisposed | −500 | $12.68 | −$6,340 | 22,969 | Direct | |
| Jun 4, 2026 | Common Stock | SSaleDisposed | −1,000 | $12.80 | −$12,800 | 21,969 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.